Putative tumour-suppressor gene <it>DAB2 </it>is frequently down regulated by promoter hypermethylation in nasopharyngeal carcinoma
<p>Abstract</p> <p>Background</p> <p>Human Disabled-2 (DAB2), is a multi-function signalling molecule that it is frequently down-regulated in human cancers. We aimed to investigate the possible tumour suppressor effect of DAB2 in nasopharyngeal carcinoma (NPC).</p>...
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2010-06-01
|
Series: | BMC Cancer |
Online Access: | http://www.biomedcentral.com/1471-2407/10/253 |
id |
doaj-50639ca2b531445e8f4de4ca03c79799 |
---|---|
record_format |
Article |
spelling |
doaj-50639ca2b531445e8f4de4ca03c797992020-11-24T22:14:39ZengBMCBMC Cancer1471-24072010-06-0110125310.1186/1471-2407-10-253Putative tumour-suppressor gene <it>DAB2 </it>is frequently down regulated by promoter hypermethylation in nasopharyngeal carcinomaChan Michael WLung Raymond WLee Tin LLeung Patrick PSo Ken KChau Shuk LNg David CTong Joanna HChan Anthony WLo Kwok WTo Ka F<p>Abstract</p> <p>Background</p> <p>Human Disabled-2 (DAB2), is a multi-function signalling molecule that it is frequently down-regulated in human cancers. We aimed to investigate the possible tumour suppressor effect of DAB2 in nasopharyngeal carcinoma (NPC).</p> <p>Methods</p> <p>We studied the expression of DAB2 in NPC cell lines, xenografts and primary tumour samples. The status of promoter methylation was assessed by methylation specific PCR and bisulfite sequencing. The functional role of DAB2 in NPC was investigated by re-introducing DAB2 expression into NPC cell line C666-1.</p> <p>Results</p> <p>Decrease or absent of <it>DAB2 </it>transcript was observed in NPC cell lines and xenografts. Loss of DAB2 protein expression was seen in 72% (33/46) of primary NPC as demonstrated by immunohistochemistry. Aberrant <it>DAB2 </it>promoter methylation was detected in 65.2% (30/46) of primary NPC samples by methylation specific PCR. Treatment of the DAB2 negative NPC cell line C666-1 with 5-aza-2'-deoxycytidine resulted in restoration of DAB2 expression in a dose-dependent manner. Overexpression of DAB2 in NPC cell line C666-1 resulted in reduced growth rate and 35% reduction in anchorage-dependent colony formation, and inhibition of serum-induced c-Fos expression compared to vector-transfected controls. Over expression of DAB2 resulted in alterations of multiple pathways as demonstrated by expression profiling and functional network analysis, which confirmed the role of DAB2 as an adaptor molecule involved in multiple receptor-mediated signalling pathways.</p> <p>Conclusions</p> <p>We report the frequent down regulation of DAB2 in NPC and the promoter hypermethylation contributes to the loss of expression of DAB2. This is the first study demonstrating frequent DAB2 promoter hypermethylation in human cancer. Our functional studies support the putative tumour suppressor effect of DAB2 in NPC cells.</p> http://www.biomedcentral.com/1471-2407/10/253 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Chan Michael W Lung Raymond W Lee Tin L Leung Patrick P So Ken K Chau Shuk L Ng David C Tong Joanna H Chan Anthony W Lo Kwok W To Ka F |
spellingShingle |
Chan Michael W Lung Raymond W Lee Tin L Leung Patrick P So Ken K Chau Shuk L Ng David C Tong Joanna H Chan Anthony W Lo Kwok W To Ka F Putative tumour-suppressor gene <it>DAB2 </it>is frequently down regulated by promoter hypermethylation in nasopharyngeal carcinoma BMC Cancer |
author_facet |
Chan Michael W Lung Raymond W Lee Tin L Leung Patrick P So Ken K Chau Shuk L Ng David C Tong Joanna H Chan Anthony W Lo Kwok W To Ka F |
author_sort |
Chan Michael W |
title |
Putative tumour-suppressor gene <it>DAB2 </it>is frequently down regulated by promoter hypermethylation in nasopharyngeal carcinoma |
title_short |
Putative tumour-suppressor gene <it>DAB2 </it>is frequently down regulated by promoter hypermethylation in nasopharyngeal carcinoma |
title_full |
Putative tumour-suppressor gene <it>DAB2 </it>is frequently down regulated by promoter hypermethylation in nasopharyngeal carcinoma |
title_fullStr |
Putative tumour-suppressor gene <it>DAB2 </it>is frequently down regulated by promoter hypermethylation in nasopharyngeal carcinoma |
title_full_unstemmed |
Putative tumour-suppressor gene <it>DAB2 </it>is frequently down regulated by promoter hypermethylation in nasopharyngeal carcinoma |
title_sort |
putative tumour-suppressor gene <it>dab2 </it>is frequently down regulated by promoter hypermethylation in nasopharyngeal carcinoma |
publisher |
BMC |
series |
BMC Cancer |
issn |
1471-2407 |
publishDate |
2010-06-01 |
description |
<p>Abstract</p> <p>Background</p> <p>Human Disabled-2 (DAB2), is a multi-function signalling molecule that it is frequently down-regulated in human cancers. We aimed to investigate the possible tumour suppressor effect of DAB2 in nasopharyngeal carcinoma (NPC).</p> <p>Methods</p> <p>We studied the expression of DAB2 in NPC cell lines, xenografts and primary tumour samples. The status of promoter methylation was assessed by methylation specific PCR and bisulfite sequencing. The functional role of DAB2 in NPC was investigated by re-introducing DAB2 expression into NPC cell line C666-1.</p> <p>Results</p> <p>Decrease or absent of <it>DAB2 </it>transcript was observed in NPC cell lines and xenografts. Loss of DAB2 protein expression was seen in 72% (33/46) of primary NPC as demonstrated by immunohistochemistry. Aberrant <it>DAB2 </it>promoter methylation was detected in 65.2% (30/46) of primary NPC samples by methylation specific PCR. Treatment of the DAB2 negative NPC cell line C666-1 with 5-aza-2'-deoxycytidine resulted in restoration of DAB2 expression in a dose-dependent manner. Overexpression of DAB2 in NPC cell line C666-1 resulted in reduced growth rate and 35% reduction in anchorage-dependent colony formation, and inhibition of serum-induced c-Fos expression compared to vector-transfected controls. Over expression of DAB2 resulted in alterations of multiple pathways as demonstrated by expression profiling and functional network analysis, which confirmed the role of DAB2 as an adaptor molecule involved in multiple receptor-mediated signalling pathways.</p> <p>Conclusions</p> <p>We report the frequent down regulation of DAB2 in NPC and the promoter hypermethylation contributes to the loss of expression of DAB2. This is the first study demonstrating frequent DAB2 promoter hypermethylation in human cancer. Our functional studies support the putative tumour suppressor effect of DAB2 in NPC cells.</p> |
url |
http://www.biomedcentral.com/1471-2407/10/253 |
work_keys_str_mv |
AT chanmichaelw putativetumoursuppressorgeneitdab2itisfrequentlydownregulatedbypromoterhypermethylationinnasopharyngealcarcinoma AT lungraymondw putativetumoursuppressorgeneitdab2itisfrequentlydownregulatedbypromoterhypermethylationinnasopharyngealcarcinoma AT leetinl putativetumoursuppressorgeneitdab2itisfrequentlydownregulatedbypromoterhypermethylationinnasopharyngealcarcinoma AT leungpatrickp putativetumoursuppressorgeneitdab2itisfrequentlydownregulatedbypromoterhypermethylationinnasopharyngealcarcinoma AT sokenk putativetumoursuppressorgeneitdab2itisfrequentlydownregulatedbypromoterhypermethylationinnasopharyngealcarcinoma AT chaushukl putativetumoursuppressorgeneitdab2itisfrequentlydownregulatedbypromoterhypermethylationinnasopharyngealcarcinoma AT ngdavidc putativetumoursuppressorgeneitdab2itisfrequentlydownregulatedbypromoterhypermethylationinnasopharyngealcarcinoma AT tongjoannah putativetumoursuppressorgeneitdab2itisfrequentlydownregulatedbypromoterhypermethylationinnasopharyngealcarcinoma AT chananthonyw putativetumoursuppressorgeneitdab2itisfrequentlydownregulatedbypromoterhypermethylationinnasopharyngealcarcinoma AT lokwokw putativetumoursuppressorgeneitdab2itisfrequentlydownregulatedbypromoterhypermethylationinnasopharyngealcarcinoma AT tokaf putativetumoursuppressorgeneitdab2itisfrequentlydownregulatedbypromoterhypermethylationinnasopharyngealcarcinoma |
_version_ |
1725797830020300800 |